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Title of file for HTML: Supplementary Information 
Description: Supplementary Figures, Supplementary Tables, Supplementary Methods, 
Supplementary References. 
 
Title of file for HTML: Supplementary Data 1 
Description: List of genes differentially expressed by RNAseq between prospective 
loser cells and WT. Sheets contain genes differentially expressed between WT and 
mahj-/- (mahjDE sheet), WT and RpS3+/- (RpS3DE sheet), or WT and RpS3*+/- 
(RpS3starDE sheet). Columns contain the following information (as indicated at the 
top): Flybase gene ID, mean expression (of normalized read counts across all samples), 
WT expression (mean of normalised read counts); mutant expression (mean of 
normalised read counts); fold change (change in expression levels between respective 
mutant and WT tissues); log2(fold change) (logarithm to base 2 of the fold change); p-
value (p-value for fold changes different from 0); FDR (p-value adjusted for multiple 
testing with the Benjamini-Hochberg procedure); symbol (Flybase gene symbol) and 
Fullname (Flybase full gene name).  
 
Title of file for HTML: Supplementary Data 2 
Description: The prospective loser cell signature. The list contains all genes that show 
significant differential expression in loser cells (i.e. mahj and at least one Rps3 mutant) 
compared to WT in a correlated manner (i.e. consistently upregulated or consistently 
downregulated in losers). Columns contain the following information (as indicated at the 
top): Flybase ID, mahj fold change (relative expression of gene in mahj-/- cells versus 
WT), mahj FDR (p-value for mahj fold change adjusted for multiple testing with the 
Benjamini-Hochberg procedure), RpS3 fold change (relative expression of gene in 
RpS3+/- cells versus WT), RpS3 FDR (p-value for RpS3 fold change adjusted for 
multiple testing with the Benjamini-Hochberg procedure), RpS3* fold change (relative 
expression of gene in RpS3*+/- cells versus WT), RpS3* FDR (p-value for RpS3* fold 
change adjusted for multiple testing with the Benjamini-Hochberg procedure), symbol 
(Flybase gene symbol) and Fullname (Flybase full gene name).  
 
Title of file for HTML: Supplementary Data 3 
Description: Table of genes differentially expressed in prospective loser cells that 
relate to the p53/DNA Damage response pathway. Columns contain the following 
information (as indicated at the top): Flybase gene ID, gene symbol (Flybase gene 
symbol), mahj fold change (change in expression levels between mahj-/- and WT 
tissues), RpS3 fold change (change in expression levels between RpS3+/- and WT 
tissues), RpS3* fold change (change in expression levels between RpS3*+/- and WT 
tissues), RpS3* FDR (p-value for RpS3* fold change adjusted for multiple testing with 
the Benjamini-Hochberg procedure). 
 
Title of file for HTML: Supplementary Data 4 
Description: List of genes differentially expressed by RNAseq between RpS3 and 
RpS3+puc wing discs. Sheets contain genes differentially expressed between RpS3 
mutant wing discs and RpS3 mutant wing discs overexpressing the gene puckered. 
Columns contain the following information (as indicated at the top): Flybase gene ID, 
mean expression (of normalized read counts across all samples), RpS3 expression (mean 
of normalised read counts); RpS3+puc expression (mean of normalised read counts); 
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fold change (change in expression levels between respective mutant and WT tissues); 
log2(fold change) (logarithm to base 2 of the fold change); p-value (p-value for fold 
changes different from 0); FDR (p-value adjusted for multiple testing with the 
Benjamini-Hochberg procedure); symbol (Flybase gene symbol) and Fullname (Flybase 
full gene name).  
 
Title of file for HTML: Supplementary Data 5 
Description: Effects of JNK inhibition on the prospective loser signature. The list 
contains the overlap between two datasets: genes within the molecular signature of loser 
cells and genes differentially expressed between RpS3 and RpS3+puc cells. Columns 
contain the following information: Flybase ID, mahj fold change (relative expression of 
gene in mahj-/- cells versus WT), mahj FDR (p-value for mahj fold change adjusted for 
multiple testing with the Benjamini-Hochberg procedure), RpS3 fold change (relative 
expression of gene in RpS3+/- cells versus WT), RpS3 FDR (p-value for RpS3 fold 
change adjusted for multiple testing with the Benjamini-Hochberg procedure), RpS3* 
fold change (relative expression of gene in RpS3*+/- cells versus WT), RpS3* FDR (p-
value for RpS3* fold change adjusted for multiple testing with the Benjamini-Hochberg 
procedure), RpS3+puc fold change (relative expression of gene in RpS3+puc versus 
RpS3), RpS3+puc FDR (p-value for RpS3+puc fold change adjusted for multiple testing 
with the Benjamini-Hochberg procedure) symbol (Flybase gene symbol) and Fullname 
(Flybase full gene name).  
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Supplementary Information 
 
 
Supplementary Methods 
 
RNAseq data generation and analysis 
Total RNA from 50 imaginal wing discs was isolated using an RNeasy Mini kit 
(Qiagen). In all cases at least two biological replicates were analysed. cDNA 
libraries were prepared from 1 μg of total RNA using TruSeq Illumina kit, 
according to the manufacturer’s protocol. The libraries were sequenced using 
Illumina HiSeq2000 or Illumina HiSeq2500 machines, obtaining at least 18 
million single-end 50 bp reads per library. The sequencing reads were 
subsequently mapped to the Flybase transcriptome (version 5.57) using the 
Burrows-Wheeler Aligner (BWA)1. Matching reads were counted per gene. The 
obtained gene counts were subjected to differential expression analysis using the 
DESeq package2 (default settings) with an FDR threshold of 0.1 (Benjamini-
Hochberg procedure). Gene Ontology was performed using DAVID 
Bioinformatics resources3. 
 
Quantitative PCR 
RNA was isolated from 15 wing discs per each sample (four biological replicates 
per genotype), dissected from female wandering L3 larvae of the indicated 
genotype. After the dissection wing discs were stored in RNAlater at -20°C 
(Qiagen Cat. no. 76104). The RNA was isolated using the RNeasy Kit (Qiagen 
Cat. no. 74104), cDNA was generated using Superscript III (Thermo Fischer Cat. 
no. 18080093) reverse transcriptase with random hexamer primers and 200ng of 
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total RNA as the template. qPCR assays were performed on CFX Connect Bio-
Rad machine using the iTaq™ Universal SYBR® Green Supermix (Bio-Rad 
Cat. no. 1725121). The following primer sequences were used: Act5c:  
aagtaccccattgagcacga, acatacatggcgggtgtgtt; Aldh: gcctggctgatctcatggaac, 
tgtaggacatgctgtagggct; Cyp6d4: ttgaaaaacactccgggattcc, gcgctctttactcttcacataca; 
Cyp9f2: ggatggccagaaagtcgagg, acgatggaagccgcatgtag; Gclc: 
gtgacatattgaaatgggg, ttccttctcattgagctgtgc; MRP: aatcgaaagtatggcgtgcag, 
ggggaatcgacagcacagt; ref(2)p: aatcgagctgtatcttttccagg, aacgtgcatattgctctcgca.  
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Supplementary Tables 
 
Supplementary Table 1: Drosophila genotypes used in the study. 
Fig. Panel Genotype Heat-shock, 
clone age 
1  hs-FLP, stauGFP/+; FRT42D, mahj/FRT42D, mahj n/a 
FRT82B, RpS3[Plac92], ubi-GFP/+ n/a 
FRT82B, RpS3*/+ n/a 
FRT42D, M(2)531/+ n/a 
2 b TRE16-dsRED/+    n/a 
c TRE16-dsRED/FRT42D, M(2)531 n/a 
d TRE16-dsRED/+; FRT82B, RpS3[Plac92], ubi-GFP/+    n/a 
f hs-FLP; Upd3-Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], ubi-GFP / FRT82B 15 min, 72 h 
g hs-FLP; Upd3-Gal4, UAS-GFP/UAS-puc; FRT82B, RpS3[Plac92], ubi-GFP / 
FRT82B 
15 min, 72 h 
h-i hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/ UAS-puc-RNAi; tub-Gal80TS/+ 30 min, 72 h 
k hs-FLP; Act>y>Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], ubi-GFP / + 10 min, 72 h 
l hs-FLP; Act>y>Gal4, UAS-GFP/UAS-puc; FRT82B, RpS3[Plac92], ubi-GFP/ + 10 min, 72 h 
m hs-FLP; Act>y>Gal4, UAS-GFP/UAS-dIAP1; FRT82B, RpS3[Plac92], ubi-GFP/ + 10 min, 72 h 
o hs-FLP; Act>y>Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], ubi-GFP / + 10 min, 72 h 
3 a-b esg-Gal4, UAS-GFP/UAS-Puc; FRT82B, RpS3[Plac92], ubiGFP/+ n/a 
c-d en-Flp; act>STOP>Gal4, UAS-GFP/UAS-puc;  FRT82B, RpS3[Plac92], ubiGFP 
/MKRS 
n/a 
4 b-c hs-FLP; 10xSTAT-GFP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 20 min, 48 h 
d-e hs-FLP; Upd3-Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B  20 min, 48 h 
f-g hs-FLP; tub>CD2>Gal4, UAS-CD8GFP/UAS-puc; upd3-lacZ/FRT82B, RpS3* 12 min, 72 h  
h UAS-DomeΔCyt/en-Gal4, UAS-GFP; +/+ n/a 
i UAS-DomeΔCyt/en-Gal4, UAS-GFP; FRT82B, RpS3[Plac92], ubi-GFP/ + n/a 
k +/hs-FLP;; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 5 min, 54 h 
l Domeg0218/hs-FLP;; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 5 min, 54 h 
n Domeg0218/hs-FLP;; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 
+/hs-FLP;; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 
Domeg0218/+;; +/FRT82B 
+/hs-FLP;; +/ FRT82B 
 
5 b hs-FLP; tub>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 n/a 
c-d hs-FLP; GstD1-GFP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B 17 min, 48h 
e-f en-Gal4, UAS-RFP/GstD1-GFP; UAS-mahjRNAi/+   n/a 
g-h en-Gal4, UAS-FLP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B n/a 
i-j en-Gal4, UAS-RFP/+; tub-Gal80TS/UAS-mahj-RNAi n/a 
6 a hh-Gal4/UAS-Nrf2 RNAi n/a 
b FRT82B, RpS3[Plac92], hh-Gal4/UAS-Nrf2 RNAi n/a 
c nub-Gal4/+; +/UAS-Nrf2    n/a 
d nub-Gal4/+; FRT82B, RpS3[Plac92] ubiGFP/UAS-Nrf2 n/a 
e  hs-FLP; tub>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 n/a 
f hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/+ 12 min, 72 h 
g hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 12 min, 72 h 
i hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 40 min, 72 h 
k hs-FLP, tub-Gal4, UAS-GFP; tub-Gal80TS/+;  FRT82B, tub-Gal80 / FRT82B, UAS-
Nrf2 
12 min, 72 h 
l, n hs-FLP, tub-Gal4, UAS-GFP; tub-Gal80TS/+;  FRT82B, RpS3[Plac92], tub-Gal80 / 
FRT82B, UAS-Nrf2 
12 min, 72 h 
o-p hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/tub-Gal80TS; puc[A251]-lacZ/UAS-Nrf2 25 min, 96 h 
Supplementary Figures 
1 a-b yw n/a  
c-d FRT82B, RpS3[Plac92], ubi-GFP/+ n/a 
e-f FRT42D, M(2)531/+ n/a 
g-h hs-FLP, stauGFP/+; FRT42D, mahj/FRT42D, mahj n/a 
i-j hs-FLP; FRT82B, RpS3[Plac92], ubi-GFP/FRT82B 12 min, 48 h 
k-l hs-FLP; FRT42D, M(2)531/ FRT42D ubi-GFP 1 h, 72h 
2 a yw n/a 
b FRT42D, M(2)531/+ n/a 
c FRT82B, RpS3[Plac92], ubi-GFP/+ n/a 
e hs-FLP; Upd3-Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], ubi-GFP / FRT82B 15 min, 72 h 
f hs-FLP; Upd3-Gal4, UAS-GFP/UAS-puc ; FRT82B, RpS3[Plac92], ubi-GFP / 
FRT82B 
15 min, 72 h 
h UAS-dIAP1/+; Hh-Gal4/+ n/a 
i yw n/a 
j yw n/a 
k hs-FLP; Act>y>Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], ubi-GFP / + n/a 
3 a hs-FLP; Act>y>Gal4, UAS-GFP/+; +/+ 10 min, 48 h 
b hs-FLP; Act>y>Gal4, UAS-GFP/+; UAS-puc/+ 10 min, 48 h 
d hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+;  FRT82B, RpS3[Plac92], tub-dsRed/+ 12 min, 72 h 
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Supplementary Table 2: GO term analysis for prospective losers signature 
genes 
 
Biological Process (GO Term) Count 
Fold 
Enrichment p-value p adj. 
oxidation reduction 43 2.35 2.00E-07 2.37E-04 
response to DNA damage stimulus 13 3.83 1.31E-04 7.49E-02 
DNA repair 12 3.99 1.87E-04 7.11E-02 
cellular response to stress 16 3.08 1.97E-04 5.67E-02 
telomere maintenance 5 11.31 7.65E-04 1.66E-01 
telomere organization 5 11.31 7.65E-04 1.66E-01 
cellular amino acid biosynthetic process 6 7.02 1.39E-03 2.41E-01 
double-strand break repair 5 8.08 2.92E-03 3.91E-01 
positive regulation of signal transduction 7 4.66 3.58E-03 4.12E-01 
positive regulation of cell communication 7 4.48 4.35E-03 4.37E-01 
 
Legend: Count (number of genes related to the biological term), Fold Enrichment 
(of genes related to biological process), p-value and adjusted p-value (adjusted 
using the Benjamini correction).  
  
e hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/UAS-BskDN;  FRT82B, RpS3[Plac92], tub-
dsRed/+ 
12 min, 72 h 
g hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+;  FRT82B, RpS3[Plac92], tub-dsRed/+ 12 min, 72 h 
h hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+;  FRT82B, RpS3[Plac92], tub-
dsRed/UAS-DrICE RNAi 
12 min, 72 h 
j hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+;  FRT82B, RpS3[Plac92], tub-dsRed/+ 12 min, 72 h 
k hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; UAS-p35/FRT82B, RpS3[Plac92], tub-
dsRed/+ 
12 min, 72 h 
4 a-b en-Gal4, UAS-FLP/+; FRT82B, RpS3[Plac92], ubi-GFP/ FRT82B n/a 
c Upd3-Gal4, UAS-GFP/+ n/a 
d hs-FLP; Upd3-Gal4, UAS-GFP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B n/a  
e upd3-LacZ/TM6B  n/a 
f upd3-LacZ/FRT82B, RpS3*  n/a 
g-h hs-FLP ; tub>CD2>Gal4, UAS-CD8-GFP/CDY; upd3-LacZ/FRT82B, RpS3* n/a 
i-j 10xSTAT-GFP/UAS-puc; FRT82B, RpS3[Plac92], hh-Gal4/+ n/a 
k-l en-Gal4, 10xSTAT-GFP/UAS-DomeΔCyt n/a 
5 a GstD1-GFP/+ n/a 
b GstD1-GFP/+; FRT82B, RpS3[Plac92], tub-dsRed/+ n/a 
d-e en-Gal4, UAS-FLP/+; FRT82B, RpS3[Plac92], ubi-GFP  / FRT82B n/a 
f-g en-Gal4, UAS-FLP/+; FRT82B, RpS3[Plac92], tub-dsRED / FRT82B n/a 
h yw n/a 
6 b hh-Gal4/UAS-Nrf2  n/a 
c FRT82B, RpS3[Plac92], hh-Gal4/UAS-Nrf2  n/a 
d +/FRT40A ; hh-Gal4/UAS-Nrf2  n/a 
e UAS-puc/FRT40A ; hh-Gal4/UAS-Nrf2 n/a 
f-g hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 20 min, 72 h 
h-i hs-FLP; tub>CD2>Gal4, UAS-CD8-GFP/+; tub-Gal80TS/UAS-Nrf2 20 min, 72 h 
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Supplementary Table 3: Toll pathway genes differentially expressed in loser 
cells. 
Gene 
symbol FC mahj FC RpS3 FC RpS3star 
pip 4.4026E-01 4.1607E-01 3.1879E-01 
Dif 4.5863E+00 3.6529E+00 6.1728E+00 
Traf4 2.4494E+00 1.7019E+00 2.2888E+00 
PGRP-SA 4.4884E+00 2.9053E+00 3.6107E+00 
spz3 1.5304E+00 1.1501E+00 1.5719E+00 
SPE 2.9996E-01 8.7552E-01 4.2304E-01  
Legend: FC mahj (fold change in expression levels between mahj-/- and WT 
tissues), FC RpS3 (fold change in expression levels between RpS3+/- and WT 
tissues), FC RpS3* (fold change in expression levels between RpS3*+/- and WT 
tissues). 
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Supplementary Figures 
 
 
 
Supplementary Figure 1. Analysis of the prospective loser cell molecular 
signature. (a-h) Representative wing discs, stained with DAPI (blue, a,c,e,g) and 
anti-cleaved caspase-3 (b,d,f,h) from WT (a-b), RpS3+/- (c-d), RpS15+/- (e-f), or 
 9 
mahj-/- (g-h) wing discs dissected from wandering third instar larvae. (i-j) RpS3+/- 
wing discs harbouring hs-FLP-induced WT clones (GFP-negative (i), 
immunostained with anti-cleaved Caspase-3 (red, j)). (k-l) Mosaic wing disc 
harbouring 1X-GFP RpS15+/- cells and 2X-GFP WT cells immunostained for 
anti-cleaved Caspase-3 (red, l). Note the absence of localised cell death (red). 
(m) Venn diagram showing the overlap of genes differentially expressed in RpS3 
and RpS3* compared to wild-type. (n) Linear regression of fold changes of 
differentially expressed genes in WT vs. RpS3 and WT vs. RpS3*; shaded area 
indicates 95% confidence interval for the fit. (o) Venn diagram showing overlap 
between loser signature genes and previously identified p53 target genes from 
two separate studies4,5. (p) List of p53 targets found in the loser signature and 
corresponding fold change increase in each loser genotype. Detailed genotypes 
for each figure panel are listed in Supplementary Table 1. Scale bars in all 
supplementary figures represent 50 μm.  
  
 10 
 
Supplementary Figure 2. Role of JNK signalling in prospective loser cells (a-
c) Immunostaining for pJNK (red) in WT (a), RpS15+/- (b) or RpS3+/- wing discs 
(c). (d) Quantification of fluorescence intensity from images as in (a-c) for the 
indicated genotypes, each dot represents a single wing disc. p-values according 
to a Welch t-test.  (e-f) Wing discs harbouring 72-hour-old GFP-negative WT 
clones within GFP-positive RpS3+/- tissue with (f) or without (e) overexpression 
of puc only in the RpS3+/- cells (achieved using upd3-Gal4 as driver), stained 
with anti-cleaved Caspase-3 (red). (g) Quantification of the number of dying 
cells occurring within a 2-cell diameter of the clonal boundary, normalised to the 
clone perimeter (competition index) for wing discs of the same genotype as in (e-
f). Each dot represents a wing disc, p-values according to Welch t-test. (h) X-ray 
irradiated WT wing disc overexpressing dIAP1 in the P compartment (right side 
of the A-P boundary labelled with white dotted line) stained with anti-cleaved 
caspase-3 (red). (i-k) Propidium iodide staining (PI, red) of a WT (i), X-ray 
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irradiated WT (j) or RpS3+/- (k) wing disc.  Detailed genotypes for each figure 
panel are listed in Supplementary Table 1. 
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Supplementary Figure 3. Effect of JNK inhibition on prospective loser cells 
(a-b) WT wing disc harbouring clones overexpressing GFP alone (a) or together 
with puc (b). (c) Size distributions (in μm2) of clones of the same genotypes as in 
(a-b), p-values according to a Welch t-test. (d-f) RpS3+/- wing disc harbouring 
clones overexpressing GFP alone (d) or together with a dominant negative form 
of Basket (BskDN, e) and corresponding clone size distributions  (f). (g-i) Similar 
to (d-f), but with clones overexpressing GFP alone (g) or together with 
knockdown of effector caspase drICE (drICE-RNAi, h). (j-l) Similar to (d-f), but 
with clones overexpressing GFP alone (j), or together with the caspase inhibitor 
p35 (k). All p-values calculated by Welch t-test. (m) Dot plot showing the 
expression of ribosomal genes upregulated greater than 1.1 fold in RpS3+/- wing 
discs upon JNK inhibition, normalized to RpS3+/- expression levels 
(RpS3+puc/RpS3). Fold changes with FDR>0.1 are in grey. Detailed genotypes 
for each figure panel are listed in Supplementary Table 1.  
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Supplementary Figure 4. Prospective losers upregulate ligands of the 
JAK/STAT pathway. (a-b) In situ hybridisation to detect upd3 mRNA (black, 
b) in a wing disc harbouring a GFP-labelled RpS3+/- A compartment and a WT P 
compartment (a) with A-P boundary outlined (white dotted line). (c) upd3-Gal4, 
UAS-GFP reporter activity in a WT wing disc. (d) Upd3-Gal4, UAS-GFP 
reporter activity in a RpS3+/- wing disc. (e) upd3-LacZ reporter activity in a WT 
wing disc. (f) Upd3-lacZ reporter activity in an RpS3*+/- wing disc. (g-h) upd3-
LacZ reporter activity (red, h) in RpS3+/- wing discs harbouring control GFP-
labelled clones (green, g). Both xy (top) and xz projections (bottom) of the same 
wing disc are presented with clones outlined (white dotted line). (i-j) 10XSTAT-
GFP reporter expression (green, j) in a RpS3+/- wing disc overexpressing puc in 
the P compartment with the A compartment labelled by immunostaining with 
anti-Ci (red, i). (k-l) 10XSTAT-GFP reporter expression (green, l) in a WT wing 
disc expressing RFP (red, k) and a dominant negative JAK/STAT receptor Dome 
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(DomeΔCyt) in the P compartment (A-P boundary labelled with white dotted line). 
Detailed genotypes for each figure panel are listed Supplementary Table 1. 
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Supplementary Figure 5. Reporters for oxidative stress in RpS3+/- cells. (a-b) 
GstD1-GFP reporter activity in WT (a) or RpS3+/- wing discs (b). (c) 
Quantification of fluorescence intensity from images as in (a-b) for the indicated 
genotypes, each dot represents a single wing disc. p-values according to a Welch 
t-test. (d-e) DHE staining (red, e) in composite wing disc harbouring a RpS3+/- A 
compartment (GFP-positive, d) and a WT (GFP-negative, d) P compartment. (f-
g) CM-H2DCFDA staining (green, g) in composite wing disc harbouring a 
RpS3+/- (dsRED positive, f) A compartment and a WT (dsRED negative, f) P 
compartment. (h) Thioltracker staining of a WT wing disc. Detailed genotypes 
for each figure panel are listed in Supplementary Table 1. 
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Supplementary Figure 6. Nrf2 overexpression and the loser status. (a) 
Quantification of the number of apoptotic cells occurring within each 
compartment of WT (left) or RpS3+/- (right) wing discs upon knockdown of Nrf2 
(hh>Nrf2-RNAi) in the P compartment. P values calculated by Wilcoxon rank 
sum test. (b-c) Overexpression of Nrf2 in the P compartment of WT (b) or 
RpS3+/- wing discs (c) stained with anti-cleaved Caspase-3 (red). (d-e) WT wing 
discs overexpressing Nrf2 and GFP (d) or Nrf2 and puc (e) in the P compartment  
(right side of A-P boundary labelled with white dotted line) stained with anti-
cleaved caspase-3 (red). (f-g) WT wing disc harbouring clones overexpressing 
Nrf2 and GFP (f) and stained with anti-cleaved Caspase-3 (red, g). A-P boundary 
(labelled with white line) is identified by Ci expression (red, f). Note that cell 
death does not occur at the A-P boundary. (h-i) Immunostaining for pJNK (red, i) 
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in WT wing discs harbouring GFP-labelled clones overexpressing Nrf2 (h). 
Detailed genotypes for each figure panel are listed in Supplementary Table 1. 
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